These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32991919)

  • 21. Older patients' perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital.
    Tegegn HG; Tefera YG; Erku DA; Haile KT; Abebe TB; Chekol F; Azanaw Y; Ayele AA
    BMJ Open; 2018 Apr; 8(4):e020590. PubMed ID: 29678983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review.
    Cardona M; Stehlik P; Fawzy P; Byambasuren O; Anderson J; Clark J; Sun S; Scott I
    Expert Opin Drug Saf; 2021 Jan; 20(1):81-91. PubMed ID: 33213216
    [No Abstract]   [Full Text] [Related]  

  • 23. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deprescribing in primary care in Portugal (DePil17-20): a three-phase observational and experimental study protocol.
    Simões PA; Santiago LM; Simões JA
    BMJ Open; 2018 Jul; 8(7):e019542. PubMed ID: 30018092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Patient Preferences in Deprescribing.
    Holmes HM; Todd A
    Clin Geriatr Med; 2017 May; 33(2):165-175. PubMed ID: 28364989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frailty, polypharmacy and deprescribing.
    Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Less Really Is More in Inappropriate Medication Use in Older Adults: How Can We Improve Prescribing and Deprescribing in Older Adults?
    Fick DM
    J Am Geriatr Soc; 2020 Jun; 68(6):1175-1176. PubMed ID: 32364621
    [No Abstract]   [Full Text] [Related]  

  • 28. Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.
    Palagyi A; Keay L; Harper J; Potter J; Lindley RI
    BMC Geriatr; 2016 Jan; 16():15. PubMed ID: 26767619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness of Pharmacist-Led Deprescribing of NSAIDs in Community-Dwelling Older Adults.
    Sanyal C; Turner JP; Martin P; Tannenbaum C
    J Am Geriatr Soc; 2020 May; 68(5):1090-1097. PubMed ID: 32105355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach to deprescribing in long-term care settings: The SMART campaign.
    Abrahamson K; Nazir A; Pressler K
    Res Social Adm Pharm; 2017 Nov; 13(6):1202-1203. PubMed ID: 27932208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New horizons in deprescribing for older people.
    Woodford HJ; Fisher J
    Age Ageing; 2019 Nov; 48(6):768-775. PubMed ID: 31595290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist's geriatric assessment.
    Bužančić I; Držaić M; Kummer I; Ortner Hadžiabdić M; Brkić J; Fialová D
    Sci Rep; 2024 Mar; 14(1):6235. PubMed ID: 38485992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polypharmacy and deprescribing: just ask the patient.
    Cave JA
    Drug Ther Bull; 2020 Jan; 58(1):2. PubMed ID: 31727779
    [No Abstract]   [Full Text] [Related]  

  • 34. Polypharmacy and Deprescribing.
    Vordenberg SE; Malani PN; Kullgren JT
    JAMA; 2023 Aug; 330(7):672. PubMed ID: 37505505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considering Value in Prescribing and Deprescribing for Older Adults.
    Levinson W
    JAMA Netw Open; 2022 Feb; 5(2):e2148606. PubMed ID: 35166789
    [No Abstract]   [Full Text] [Related]  

  • 36. Community-dwelling older people's attitudes towards deprescribing in Canada.
    Sirois C; Ouellet N; Reeve E
    Res Social Adm Pharm; 2017; 13(4):864-870. PubMed ID: 27663392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicians need to take the lead in deprescribing.
    Scott IA; Le Couteur DG
    Intern Med J; 2015 Mar; 45(3):352-6. PubMed ID: 25735580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A set of systematic reviews to help reduce inappropriate prescribing to older people: study protocol.
    Martinez YV; Renom-Guiteras A; Reeves D; Erandie Ediriweera de Silva R; Esmail A; Kunnamo I; Rieckert A; Sommerauer C; Sönnichsen A
    BMC Geriatr; 2017 Oct; 17(Suppl 1):231. PubMed ID: 29047332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review.
    Sawan M; Reeve E; Turner J; Todd A; Steinman MA; Petrovic M; Gnjidic D
    Expert Rev Clin Pharmacol; 2020 Mar; 13(3):233-245. PubMed ID: 32056451
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug Prescribing: Polypharmacy and Deprescribing.
    McQuade BM; Campbell A
    FP Essent; 2021 Sep; 508():33-40. PubMed ID: 34491710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.